HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Vries, W.J. Articles by Long, M.A. Search for Related Content PubMed PubMed Citation Articles by de Vries, W.J. Articles by Long, M.A. Related Collections Lung - cancer Pleura

Eur J Cardiothorac Surg 2003;24:434-440
© 2003 Elsevier Science NL

Treatment of mesothelioma in Bloemfontein, South Africa

Cardiothoracic Department, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa

Received 12 December 2002; received in revised form 24 May 2003; accepted 26 May 2003.

^* Corresponding author. Tel: +27-51-405-3435; fax: +27-51-443-440
e-mail: gnktwdv{at}med.uovs.ac.za

Objective: Two different surgical methods for treating mesothelioma (pleurectomy and pleuro pneumonectomy) were reviewed. Methods: This was a retrospective study from 1976 to 2001. Forty-six patients, aged 35–80 years, received one of the following procedures: pleurectomy (n=29), or pleuro pneumonectomy (n=17). Pleurectomy was indicated in symptomatic patients with pain or pleural effusion while pleuro pneumonectomy was indicated in patients with Butchart stage I or II disease and an acceptable cardiopulmonary reserve. Patients received either chemotherapy, radiation, or in combination after surgery. Results: The mortality rate was 3.8% for pleurectomy patients and 5.8% for pleuro pneumonectomy patients. The median survival rate for pleurectomy patients was 9 months, and 12 months for pleuro pneumonectomy patients. Pleuro pneumonectomy patients experienced less morbidity and had a shorter hospital stay than pleurectomy patients. Conclusions: Improved survival was obtained with both procedures. Morbidity was higher in the patients who underwent pleurectomy. Important prognostic factors include tumor stage, tumor histology, duration of symptoms, and weight loss or pain as a presenting symptom. Patients with a low tumor stage, epithelial histology, absence of pain or weight loss, and a longer onset of symptoms had the best survival rate. A trend towards improved survival in patients undergoing pleuro pneumonectomy and receiving radiation as adjuvant therapy was observed.

Key Words: Mesothelioma • Pleurectomy • Pleuro pneumonectomy

This article has been cited by other articles:

				S. Neragi-Miandoab Multimodality approach in management of malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 14 - 19. [Abstract] [Full Text] [PDF]